MTOR and lymphoma: Shi et al. 165 have provided the first evidence of the in vitro and in vivo activity of metformin in human lymphoma cells, demonstrating that the activity of drug on AMPK inhibits the growth of B and T cell lymphomas by inhibiting mTOR signaling without the involvement of AKT.